Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored

On Feb. 3, the House of Representatives passed the Senate Amendment to H.R. 7148, the Consolidated Appropriations Act, 2026, by a vote of 217 to 214. Later that day, President Donald Trump signed the bill into law, officially ending the brief partial government shutdown that began on Jan. 31.

Sylvester opens Griffin Cancer Research Building

Sylvester Comprehensive Cancer Center has announced the opening of the Kenneth C. Griffin Cancer Research Building. The building has doubled Sylvester’s research footprint, breaking down barriers between scientific research and patient care.

February 06, 2026

Vol.52 No.05

Podcast

The soul of oncology: Centering patient stories amid funding saga

Last week’s issue of The Cancer Letter included an obituary that the entire staff at The Cancer Letter had been dreading for years: Abdallah Abou Zahr, an oncologist at Roger Maris Cancer Center in Fargo, ND, died Jan. 23 of a liposarcoma after a five-year battle with the disease.

February 04, 2026

Capitol Hill

FY26 funding package blocked in Senate after ICE shooting of Alex Pretti
New package—likely excluding DHS—may go back to House early next week

An argument can be made that anyone who has attempted to follow the path of spending bills on Capitol Hill over the past ten days should be evaluated for whiplash.

Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill

Sometime next week, the Senate is expected to vote on a legislative package that would determine the fiscal year 2026 spending levels for much of the federal government. xxx:moreReaders of The Cancer Letter may be breathing a sigh of relief that NIH seems like

Trodelvy + Keytruda show potential as new standard of care in first-line PD-L1+ metastatic TNBC, phase III trial finds

Patients saw a 35% reduced risk of disease progression or death for Trodelvy (sacituzumab govitecan-hziy) plus Keytruda (pembrolizumab) (n=221) versus standard of care Keytruda plus chemotherapy (n=222), according to the positive phase III ASCENT-04/KEYNOTE-D19 study evaluating the combination of Trodelvy plus Keytruda in first-line PD-L1+ (CPS ≥10) metastatic triple-negative breast cancer.

January 23, 2026

Vol.52 No.03

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

YOU MAY BE INTERESTED IN

After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored

Sylvester opens Griffin Cancer Research Building

The soul of oncology: Centering patient stories amid funding saga

FY26 funding package blocked in Senate after ICE shooting of Alex Pretti
New package—likely excluding DHS—may go back to House early next week

Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill

Trodelvy + Keytruda show potential as new standard of care in first-line PD-L1+ metastatic TNBC, phase III trial finds

Renew today!

Subscriber content

Never miss an issue!

Login

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

YOU MAY BE INTERESTED IN

After a brief government shutdown, FY26 funding bill is signed into lawNIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored

Sylvester opens Griffin Cancer Research Building

The soul of oncology: Centering patient stories amid funding saga

FY26 funding package blocked in Senate after ICE shooting of Alex PrettiNew package—likely excluding DHS—may go back to House early next week

Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill

Trodelvy + Keytruda show potential as new standard of care in first-line PD-L1+ metastatic TNBC, phase III trial finds

Never miss an issue!

Login

After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored

FY26 funding package blocked in Senate after ICE shooting of Alex Pretti
New package—likely excluding DHS—may go back to House early next week